Marie Brevet

Implementing digital pathology: qualitative and financial insights from eight leading European laboratories

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Different Genetic Signatures of Small‐Cell Lung Cancer Characterize <scp>Anti‐GABA_BR</scp> and <scp>Anti‐Hu</scp> Paraneoplastic Neurological Syndromes

Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling

Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer

Uncommon EGFR mutations in lung adenocarcinoma: features and response to tyrosine kinase inhibitors

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

SMARCA4-deficient Thoracic Sarcomas

A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management

Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma

Evaluation of pre-analytical conditions and comparison of the performance of several digital PCR assays for the detection of major <i>EGFR</i> mutations in circulating DNA from non-small cell lung cancers: the CIRCAN_0 study

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone

Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)